
About Saluda Medical
Saluda Medical is a publicly listed company based in Bloomington (United States) founded in 2010. Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment. Saluda Medical has raised $530 million across 9 funding rounds from investors including Fidelity Investments, Medtronic and Boston Scientific. Its chief executive, as recorded, is Jim Schuermann. Saluda Medical offers products and services including Evoke System and SmartLoop Technology. Its focus areas include Life Sciences, Pain Management, Medical Devices and Therapeutic Devices. Its legal entity is SALUDA MEDICAL EUROPE LIMITED. Its competitors include Myoscience, Nalu Medical and Neuros Medical; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.
- Annual Revenue$91.65 M (USD)22.5as on Jun 30, 2026
- Net Profit-$152.02 M (USD)4.26as on Jun 30, 2026
- EBITDA-$148.47 M (USD)-19.94as on Jun 30, 2026
- Total Equity Funding$530M (USD)
in 9 rounds
- Latest Funding Round$30M (USD), Series B
Oct 2025
- InvestorsFidelity Investments
& 10 more
Products & Services of Saluda Medical
Saluda Medical offers a comprehensive portfolio of products and services, including Evoke System and SmartLoop Technology.
Device for closed-loop spinal cord stimulation to treat chronic pain.
Technology that adjusts neural stimulation based on patient responses.
Apps and channels of Saluda Medical
its YouTube channel Saluda Medical has 695 subscribers and 23 videos.
Videos from Saluda Medical
The most watched videos on Saluda Medical's YouTube channel, Saluda Medical (695 subscribers). Click a video to play it here.
More on Saluda Medical.
Funding Insights of Saluda Medical
Saluda Medical has successfully raised a total of $530M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $530M
- Total Rounds 9
- Last Round Series B — $30M
- First Round $10M
(Feb 2012)
- Investors Count 11
All 9 funding rounds of Saluda Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2025 | $30M | Series B | – | – | – |
| Jan 2025 | $100M | Series F | – | Redmile Group | |
| Apr 2023 | $150M | Series F | – | Wellington | |
| Mar 2022 | $125M | Series F | – | Redmile Group | |
| Jun 2019 | $75M | Series E | – | Boston Scientific, Redmile Group | – |
| Jun 2019 | Debt – Conventional | – | – | ||
| May 2017 | $40M | Series D | – | Action Potential Venture Capital | |
| Jul 2013 | $5M | Grant | – | – | |
| Feb 2012 | $10M | Series B | – | BioScience Managers | – |
11 investors in total: 11 institutional.
Investors in Saluda Medical
Saluda Medical has secured backing from 11 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments, Medtronic and Boston Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Fund of funds focused on pre-seed and seed-stage companies | 1992 | tpg.com | Fort Worth, United States | |
Stage-agnostic investments in US life sciences are pursued. | actionpotentialvc.com | Palo Alto, United States | ||
BioScience Managers is engaged in healthcare investment and innovation. | biosciencemanagers.com | Melbourne, Australia | ||
Operates as an employee-owned hedge fund focused on long/short equity strategies. | 2007 | redmilegroup.com | San Francisco, United States | |
Diversified investment management services are provided to institutional clients. | wellington.com | Boston, United States | ||
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms | 1946 | fidelity.com | Boston, United States | |
Diversified asset management services are provided to investors globally. | 1937 | troweprice.com | Baltimore, United States | |
Wide range of medical devices | 1979 | bostonscientific.com | Marlborough, United States | |
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | medtronic.com | Minneapolis, United States | |
NSW Health is tasked with providing public health services across New South Wales. | health.nsw.gov.au | St Leonards, Australia |
Investor details for Saluda Medical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Saluda Medical
145 people are tracked at Saluda Medical (27 in leadership, 118 in team).
| Name | Role | Group |
|---|---|---|
Jim Schuermann | CEO | Leadership |
Dean Karantonis | VP of Therapy Development | Leadership |
Kyle Schreiner | Senior Regional Director | Leadership |
Dave Mugan | VP & Head of EU Operations | Leadership |
Brandon Governale | Regional Director | Leadership |
Loren Buchanan | Director, Global Commercial Marketing | Leadership |
Sadie Mauser | Director Of Quality | Leadership |
Nicole Soliday | Head Of Clinical Evidence | Leadership |
Danielle Fried | Senior Regional Sales Director | Leadership |
Tim Johnson | West Vice President | Leadership |
Andrew Hancock | Director Of Manufacturing | Leadership |
Ryan Bohlen | Associate Director - Supply Chain | Leadership |
Holger Krauss | Area Director DACH | Leadership |
Kappy Pauna | Sr. Director, Human Resources | Leadership |
Nancy O'Connell | Director Global Clinical Operations | Leadership |
Rac Erika Huffman | Regulatory Project Director | Leadership |
Bekezela Ngwenya | Director, Operations Quality | Leadership |
Daniela Mlynek | Senior Clinical Specialist & Clinical Excellence Partner Germany | Leadership |
Georgina Clare | Vice President Human Resources | Leadership |
Quynh Stella | Sr. Director, Product Management | Leadership |
125 more people are available in the full profile.
Complete people profiles for Saluda Medical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Saluda Medical
Saluda Medical is a publicly listed company on the ASX with ticker symbol SLD in Australia. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Dec 2025
- Listed onASX: SLD
- Listed entitySaluda Medical Inc
- ISINAU0000432114
- Share price0.39 AUD (-2.53% on the day) · 2026-10-14
- Market capitalisation104,589,881.15 AUD
- EPS (diluted, trailing year)-0.87 AUD
- Volume (last session)235,093
Financials of Saluda Medical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2026 | 133.1M AUD | -220.7M AUD | -215.6M AUD |
| 2025 | 108.6M AUD | -230.5M AUD | -179.7M AUD |
| 2024 | 78.9M AUD | -149.3M AUD | -148.4M AUD |
| 2023 | 33.0M AUD | -137.0M AUD | -135.2M AUD |
Detailed financial statements for Saluda Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Saluda Medical
4 dated milestones of Saluda Medical across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Saluda Medical is founded.
- Funding First funding round of $10.0M.
- Funding Latest funding round, Series B, of $30.0M.
- IPO Lists on the stock exchange (IPO).
Competitors of Saluda Medical
Saluda Medical has 3 listed competitors in our database, 3 of them funded. They include Myoscience, Nalu Medical and Neuros Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| myoscience.com | 2005 | Redwood, United States | $147.68M | 687 | Technology-driven dermatological products are developed and commercialized. | |
| nalumed.com | 2014 | Carlsbad, United States | $230.97M | Developer of a neurostimulation system for managing intractable chronic pain | ||
| neurosmedical.com | 2008 | Cleveland, United States | $145.2M | 28 | High-frequency neurostimulation therapies for chronic neuropathic pain are developed. |
Detailed competitors of Saluda Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Saluda Medical
The website of Saluda Medical (saludamedical.com) receives about 8.5K visits a month.
- Monthly visits8.5K
▼ 56% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Saluda Medical (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Saluda Medical
Complete news archive for Saluda Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saluda Medical
Saluda Medical was founded in 2010 and raised its 1st funding round 2 years after it was founded.
Saluda Medical is headquartered in Bloomington, United States. It is registered at Bloomington, Indiana, United States.
Jim Schuermann is the CEO of Saluda Medical, as recorded in our data.
Saluda Medical is a funded company, having raised a total of $530M across 9 funding rounds to date. The company's 1st funding round was a Series B of $10M, raised on Feb 2012.
Annual revenue of Saluda Medical is $91.65M as on Jun 30, 2026.
Founded in 2010 and headquartered in Bloomington, United States, Saluda Medical operates in the neuromodulation sector. A system is provided that measures and records neural activation characteristics for treating chronic neurological conditions, particularly pain. Stimulation levels are quantified against clinician-defined targets, with continuous comparisons and automatic adjustments to maintain consistent activation. Evoked Compound Action Potentials are utilized to enhance therapy precision.
Saluda Medical's top competitors include Nalu Medical, Myoscience and Neuros Medical.
Saluda Medical offers Evoke System and SmartLoop Technology.
Yes, Saluda Medical is publicly traded on ASX under the ticker symbol SLD.
Saluda Medical has 11 investors. Key investors include Fidelity Investments, Medtronic, Boston Scientific, TPG, and T. Rowe Price.
Saluda Medical operates through Saluda Medical Europe Limited.
